Te Li Chen
Chief Executive Officer chez BIOGEND THERAPEUTICS CO., LTD.
Profil
Te Li Chen is currently the Chairman & General Manager at BioGend Therapeutics Co., Ltd.
and a Non-Executive Director at Jacobio Pharmaceuticals Group Co., Ltd.
He previously served as the Chairman at Mycenax Biotech, Inc. and as a Director at TPG Biologics, Inc. Prior to that, he was an Associate Professor at National Yang Ming University from 2006 to 2016.
Dr. Chen holds an undergraduate degree from National Defense Medical Center, conferred in 1995, and a doctorate degree from National Yang Ming University, conferred in 2008.
Postes actifs de Te Li Chen
Sociétés | Poste | Début |
---|---|---|
BIOGEND THERAPEUTICS CO., LTD. | Chief Executive Officer | 07/07/2016 |
JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Director/Board Member | 20/08/2020 |
Anciens postes connus de Te Li Chen
Sociétés | Poste | Fin |
---|---|---|
National Yang Ming University | Corporate Officer/Principal | 01/01/2016 |
TPG BIOLOGICS INC | Director/Board Member | - |
MYCENAX BIOTECH INC. | Chairman | - |
Formation de Te Li Chen
National Defense Medical Center | Undergraduate Degree |
National Yang Ming University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
MYCENAX BIOTECH INC. | Health Technology |
BIOGEND THERAPEUTICS CO., LTD. | Commercial Services |
JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
TPG Biologics, Inc.
TPG Biologics, Inc. Pharmaceuticals: MajorHealth Technology TPG Biologics, Inc. engages in the development of biopharmaceutical products. It offers antibody and protein drug design, cell line generation, process development, monoclonal antibody cell line similar drug products, and biological production for feasibility tests and animal studies. The company was founded on December 31, 2003 and headquartered in Taipei, Taiwan. | Health Technology |